Company Name: Vektor Medical
Location: San Diego, CA
Sector: Healthcare Technology
Funding Details: Raised $16m in Series A funding, co-led by Solas BioVentures and TVM Capital Life Science.
Purpose of Investment: To commercialize vMap®, Vektor’s AI-based arrhythmia analysis tool, including increasing clinical support, conducting additional clinical studies, and securing reimbursement.
Leadership: CEO Rob Krummen
Product: vMap, an FDA-cleared, non-invasive AI-based solution for arrhythmia localization and analysis using a 12-lead ECG. It provides physicians with critical information for understanding arrhythmia sources and optimizing cardiac ablation outcomes.
About Company: Vektor Medical is at the forefront of non-invasive, AI-based arrhythmia analysis technology. Their flagship product, vMap, aims to transform cardiac care by improving outcomes, optimizing workflows, and increasing procedural efficiency.